Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Maybio Matrix logo — Advancing the future of maxillofacial tissue regeneration wi...

Maybio Matrix

Advancing the future of maxillofacial tissue regeneration with innovative biological scaffold solutions for both medical and aesthetic applications.

Founded 2019 Series A Biopharma, Biotechnology

General Information

Company Name Maybio Matrix
Founded Year 2019
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

Get notified when Maybio Matrix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Maybio Matrix

Maybio Matrix is a biopharmaceutical and biotechnology startup founded in 2019. The company is dedicated to advancing the future of maxillofacial tissue regeneration with innovative biological scaffold solutions for both medical and aesthetic applications. The description of the company highlights its focus on research and development, production, and sales of biological scaffold material tailored for maxillofacial tissue regeneration, addressing medical, plastic, and cosmetic clinical needs. Maybio Matrix recently secured a significant milestone by receiving a Series A investment on 14 September 2023. The investment was led by Caixin Industry Fund, Sunz Fund, and Xinhangcheng Holdings, showcasing a strong vote of confidence from prominent investors in the industry. This influx of capital is expected to fuel the company's growth and propel its innovative solutions into the market, potentially shaping the future of maxillofacial tissue regeneration. Overall, Maybio Matrix stands as a promising player in the biopharma and biotechnology industries, with a clear focus on pioneering solutions in the field of maxillofacial tissue regeneration. The recent Series A investment indicates a bright outlook for the company, highlighting its potential to make a significant impact in the medical and aesthetic realms.

Taxonomy: Biological Scaffold, Tissue Regeneration, Maxillofacial Surgery, Medical Applications, Aesthetic Applications, Biomedical Research, Regenerative Medicine, Plastic Surgery, Cosmetic Surgery, Bioengineering, Clinical Needs

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3 •••• •••• 14 Sep 2023
Series A •••••• 3
Investor
•••• •••• 		16 Aug 2021
Angel Round •••••• 1 •••• •••• 09 Feb 2021

Maybio Matrix Alternatives & Competitors

Maybio Matrix vs
Anchora Medical Ltd.
Anchora Medical Ltd. Israel

Anchora is developing a unique, single-use automatic suturing device for minimal invasive surgery

Series B
5 employees
Health Care, Medical Devices
Maybio Matrix vs
FzioMed, Inc.
FzioMed, Inc. United States

Preserve Surgical Excellence.

36 employees
Biotechnology, Health Care
Maybio Matrix vs
Industrie Biomediche Insubri SA
Industrie Biomediche Insubri SA Switzerland

IBI-SA is a hi-tech Swiss biomedical company focused on regenerative medicine.

Series A
14 employees
Biotechnology, Medical Devices

FAQ About Maybio Matrix

Advancing the future of maxillofacial tissue regeneration with innovative biological scaffold solutions for both medical and aesthetic applications.
Maybio Matrix was founded in 2019.
Maybio Matrix operates in the following industries: Biopharma, Biotechnology.
Maybio Matrix has completed 3 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to Maybio Matrix include Anchora Medical Ltd., FzioMed, Inc., Industrie Biomediche Insubri SA, Markman Biologics, Dune Medical Devices. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Maybio Matrix and Anchora Medical Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Maybio Matrix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy